# A Study to Compare Oral Formulations of Tedizolid Phosphate in Healthy Adults (MK-1986-044)

> **NCT06609161** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tedizolid Phosphate Oral Formulation 1 (Reference)
- **DRUG:** Tedizolid Phosphate Oral Formulation 2 (Test)

## Key facts

- **NCT ID:** NCT06609161
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-16
- **Primary completion:** 2024-08-08
- **Final completion:** 2024-08-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06609161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06609161, "A Study to Compare Oral Formulations of Tedizolid Phosphate in Healthy Adults (MK-1986-044)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06609161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*